Can you prevent adverse drug events after hospital discharge?

CMAJ. Canadian Medical Association Journal

Volumn 174, Issue 7, 2006, Pages 921-922

  Forster, Alan J ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; WARFARIN;

AGED; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOLOGIC DISEASE; HOSPITAL DISCHARGE; HUMAN; HYPOGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT MONITORING; PRESCRIPTION; SIDE EFFECT; STROKE;

EID: 33645563300     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.050983     Document Type: Article

References (3)

1. Forster AJ, Murff HJ, Peterson JF, et al. Adverse drug events occurring following hospital discharge. J Gen Intern Med 2005;20:317-23.
2. Forster AJ, Clark HD, Menard A, et al. Adverse events affecting medical patients following discharge from hospital [published erratum in CMAJ 2004;170(5):771]. CMAJ 2004;170(3):345-9.
3. Kovacs MJ, Rodger M, Anderson DR, et al. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism: a randomized, double-blind, controlled trial. Ann Intern Med 2003;138:714-9.